COSMOS Pharmaceutical (TSE:3349) EBIT per Share : 円872.30 (TTM As of Feb. 2024)

View and export this data going back to 2004. Start your Free Trial

What is COSMOS Pharmaceutical EBIT per Share?

COSMOS Pharmaceutical's EBIT per Share for the three months ended in Feb. 2024 was 円220.72. Its EBIT per Share for the trailing twelve months (TTM) ended in Feb. 2024 was 円872.30.

During the past 12 months, the average EBIT per Share Growth Rate of COSMOS Pharmaceutical was 5.40% per year. During the past 3 years, the average EBIT per Share Growth Rate was 1.20% per year. During the past 5 years, the average EBIT per Share Growth Rate was 6.20% per year. During the past 10 years, the average EBIT per Share Growth Rate was 8.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for COSMOS Pharmaceutical's EBIT per Share or its related term are showing as below:

TSE:3349' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -4 Med: 10 Max: 34.8
Current: 1.2

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of COSMOS Pharmaceutical was 34.80% per year. The lowest was -4.00% per year. And the median was 10.00% per year.

TSE:3349's 3-Year EBIT Growth Rate is ranked worse than
63.91% of 507 companies
in the Healthcare Providers & Services industry
Industry Median: 8 vs TSE:3349: 1.20

COSMOS Pharmaceutical's EBIT for the three months ended in Feb. 2024 was 円8,747 Mil.

COSMOS Pharmaceutical EBIT per Share Historical Data

The historical data trend for COSMOS Pharmaceutical's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

COSMOS Pharmaceutical EBIT per Share Chart

COSMOS Pharmaceutical Annual Data

Trend

May14

May15

May16

May17

May18

May19

May20

May21

May22

May23

EBIT per Share

Get a 7-Day Free Trial

687.29

769.49

976.19

835.88

828.91

COSMOS Pharmaceutical Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
EBIT per Share	Get a 7-Day Free Trial															188.87	216.12	243.80	191.66	220.72

COSMOS Pharmaceutical EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

COSMOS Pharmaceutical's EBIT per Share for the fiscal year that ended in May. 2023 is calculated as

	EBIT per Share		(A: May. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	32824	/	39.599
=	828.91

COSMOS Pharmaceutical's EBIT per Share for the quarter that ended in Feb. 2024 is calculated as

	EBIT per Share		(Q: Feb. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	8747	/	39.629
=	220.72

EBIT per Share for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円872.30

COSMOS Pharmaceutical (TSE:3349) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

COSMOS Pharmaceutical EBIT per Share Related Terms

Thank you for viewing the detailed overview of COSMOS Pharmaceutical's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

COSMOS Pharmaceutical (TSE:3349) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » COSMOS Pharmaceutical Corp (TSE:3349) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

4 floor,10th first Fukuoka S Building Museum, Hakataekihigashi 2-chome,, Fukuoka, JPN, 812-0013

Website

http://www.cosmospc.co.jp

COSMOS Pharmaceutical Corp manages retail drugstores in Japan. The company places a strong emphasis on convenience regarding its product selection, which includes medical products, health and beauty aids, personal-care items, discount cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, alcoholic beverages, tobacco, insect repellent, and miscellaneous everyday consumables. The majority of the company's revenue is derived from common grocery sales. Cosmos also operates a private grocery brand called ON 365.

COSMOS Pharmaceutical (TSE:3349) Headlines

No Headlines